Skip to content
Open access

Split Activator Assembly via Aptamer Binding Enables CRISPR-Cas12a Activation with Non-Nucleic Acid Targets

Sep 2026 · Small Methods · Vol 10, pp. e71075 - e71075 · 0 citations · 36 references
Medicine

Abstract

The programmability of CRISPR-Cas12a has enabled transformative advances in nucleic acid detection; however, extending its activation to non-nucleic-acid targets remains highly desirable. Here, we report a universal split-activator strategy that enables programmable Cas12a activation in response to a small molecule and a protein. In this approach, a canonical activator is divided into two fragments (p1 and p2), such that Cas12a activation occurs only upon their simultaneous assembly. We integrate this mechanism with aptamer-mediated conformation switching, wherein target binding destabilizes an aptamer-p2 duplex, releasing p2 to complete the activator complex and trigger Cas12a nuclease activity. Using this design, we demonstrate selective recognition of the small-molecule metabolite adenosine and the protein biomarker prostate-specific antigen (PSA), with high specificity against structurally related controls. Signal generation is achieved using fluorescent DNA nanoclusters (DFN-1), which undergo fluorescence decrease upon Cas12a-mediated degradation. The system exhibits concentration-dependent responses for both targets. Together, this work establishes a modular framework for coupling aptamer-based molecular recognition to programmable Cas12a activation, expanding the functional scope of CRISPR systems beyond nucleic acids and enabling new opportunities in CRISPR-Cas12a-mediated detection.

Read PDF

Similar papers

Sep 2026

An aptamer-regulated CRISPR/Cas12a system based on split crRNA for theophylline and tobramycin detection.

Most existing CRISPR/Cas12a methods for small molecules detection employ DNA aptamers as an intermediary, while RNA aptamers remain underexplored. The conventional CRISPR/Cas12 system offers limited programmability due to its partially conserved crRNA sequence. In this study, we developed an aptamer-regulated CRISPR/Ca...

Jin-Ming Liu, Le Li, Zi-Wen Tang et al. · 0 citations
#gene editing Oct 2026

Programmable thermoregulation of the nuclease activity of LbCas12a.

CRISPR-Cas12a holds great promise for molecular diagnostics and gene editing due to its sequence-specific DNA recognition and robust trans-cleavage activity, yet precise tuning of its nuclease activity remains challenging. Herein, we report a simple temperature-regulation strategy using cost-effective ssDNA blockers, t...

Shi-Wen Tang, Xin-Yi Liao, Jun-Hong Chen et al. · 0 citations
Oct 2026

A DNAzyme-activated engineered crRNA enables CRISPR-Cas12a biosensing of ALP and S. aureus.

A CRISPR-Cas12a biosensor centered on a DNAzyme-activated engineered crRNA, enabling Mn2+-responsive control over its trans-cleavage activity for nucleic-acid-amplification-free detection and establishing a powerful platform for biosensing.

Xin-Rui Wang, Xue-Ning Shi, Xiao-Xi Zheng et al. · 0 citations
Open access Oct 2026

Photo-Removable CRISPR-Cas12a Systems for Programmable Translational Modulation

Messenger RNA (mRNA) has emerged as a powerful tool for developing new therapeutics and biotechnologies due to its inherent ability to express proteins. However, the lack of precise control over protein expression remains a critical limitation for mRNA-based biomedical applications. Herein, we developed a novel photo...

Sheng Li, Han Li, Yu-Ling Teng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.